{"id":7023,"date":"2025-05-22T13:15:04","date_gmt":"2025-05-22T10:15:04","guid":{"rendered":"https:\/\/jordan-cardiac.org\/?p=7023"},"modified":"2025-05-22T13:15:04","modified_gmt":"2025-05-22T10:15:04","slug":"pci-outcomes-in-patients-with-prior-tavr-key-findings-from-a-2025-study","status":"publish","type":"post","link":"https:\/\/jordan-cardiac.org\/en\/pci-outcomes-in-patients-with-prior-tavr-key-findings-from-a-2025-study\/","title":{"rendered":"PCI Outcomes in Patients with Prior TAVR: Key Findings from a 2025 Study"},"content":{"rendered":"
PCI Outcomes in Patients with Prior TAVR: Key Findings from a 2025 Study<\/div>\n
1. Study Objective:<\/span><\/div>\n
To evaluate the success and risks of PCI in patients with a history of transcatheter aortic valve replacement (TAVR), using data from the ACC\u2019s CathPCI Registry (2011\u20132017).<\/div>\n
2. Population Studied:<\/span><\/div>\n
\u2022 Over 52,000 Medicare fee-for-service patients who underwent TAVR.<\/span><\/div>\n
\u2022 Among them, 5.1% had PCI within 5 years.<\/span><\/div>\n
\u2022 Compared with >5,000 propensity-matched patients who underwent PCI without prior TAVR.<\/span><\/div>\n
3. PCI Success Rates:<\/span><\/div>\n
\u2022 PCI success:<\/span><\/div>\n
\u2022 91.6% in post-TAVR patients<\/div>\n
\u2022 92.4% in non-TAVR patients<\/div>\n
\u2022 No statistically significant difference.<\/span><\/div>\n
4. Procedural Differences:<\/span><\/div>\n
\u2022 Fluoroscopy time:<\/span><\/div>\n
\u2022 21.9 minutes (post-TAVR) vs. 17.7 minutes (non-TAVR)<\/div>\n
\u2022 Post-procedure stroke rate:<\/span><\/div>\n
\u2022 0.8% (post-TAVR) vs. 0.4%<\/div>\n
\u2022 Bleeding rate:<\/span><\/div>\n
\u2022 5.1% (post-TAVR) vs. 2.9%<\/div>\n
5. Long-Term Outcomes (3-Year Follow-Up):<\/span><\/div>\n
\u2022 Higher rate of repeat PCI in the TAVR group<\/span><\/div>\n
\u2022 Similar rates of AMI between groups<\/span><\/div>\n
\u2022 Stroke and death were more frequent in post-TAVR patients<\/span><\/div>\n
6. Technical Challenges in Post-TAVR PCI:<\/span><\/div>\n
\u2022 Difficult coronary engagement<\/span><\/div>\n
\u2022 Limited catheter support, especially with self-expanding valves<\/span><\/div>\n
7. Possible Explanations for Adverse Outcomes:<\/span><\/div>\n
\u2022 Increased procedural complexity<\/span><\/div>\n
\u2022 Less frequent use of antiplatelets\/anticoagulants<\/span><\/div>\n
\u2022 Possible intrinsic bleeding risks in aortic stenosis patients<\/span><\/div>\n
8. Limitations of the Study:<\/span><\/div>\n
\u2022 All patients were Medicare beneficiaries (limits generalizability)<\/span><\/div>\n
\u2022 Type of TAVR valve not specified<\/span><\/div>\n
<\/div>\n
Source:<\/div>\n
The American Journal of Cardiology, 2025., May 14, 2025.<\/div>\n
Published summary of: Lalani C. et al.<\/div>\n
https:\/\/www.ajconline.org\/article\/S0002-9149(25)00294-2\/fulltext<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"

PCI Outcomes in Patients with Prior TAVR: Key Findings from a 2025 Study 1. Study Objective: To evaluate the success and risks of PCI in patients with a history of transcatheter aortic valve replacement (TAVR), using data from the ACC\u2019s CathPCI Registry (2011\u20132017). 2. Population Studied: \u2022 Over 52,000 Medicare fee-for-service patients who underwent TAVR. […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-7023","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/7023","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/comments?post=7023"}],"version-history":[{"count":1,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/7023\/revisions"}],"predecessor-version":[{"id":7024,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/7023\/revisions\/7024"}],"wp:attachment":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/media?parent=7023"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/categories?post=7023"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/tags?post=7023"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}